Jeffrey Sterling
Research and Development Division
Teva Pharmaceutical Industries
Abic, P.O. Box 8077
Netanya 42504
Israel
Name/email consistency: high
- Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease. Sterling, J., Herzig, Y., Goren, T., Finkelstein, N., Lerner, D., Goldenberg, W., Miskolczi, I., Molnar, S., Rantal, F., Tamas, T., Toth, G., Zagyva, A., Zekany, A., Finberg, J., Lavian, G., Gross, A., Friedman, R., Razin, M., Huang, W., Krais, B., Chorev, M., Youdim, M.B., Weinstock, M. J. Med. Chem. (2002)